IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Nvidia partners with industry leaders in life sciences to use AI for drug discovery, genomics research, and healthcare innovation. Read more here.

A partnership with biotechnology firm Illumina Inc. aims to unlock insights from genomics data by combining Illumina’s ...

Systemic Bio™, a 3D Systems company (NYSE: DDD), is honored to announce its selection as a Top 10 Finalist for the ...

Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to ...

A tunnel along the border wall in Texas, going from Mexico into the U.S. and believed to have been used by smugglers, was ...

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

Deal values Aragen at approximately $1.4 billion, with Quadria acquiring a minority stake through a combination of fresh ...

The deal values privately held Truveta at more than $1 billion, it said. Biotechnology company Regeneron pledged to put in ...

Wockhardt, founded in 1967, now has six novel formulations in the pipeline, with a second drug Zaynich also expected to ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...